Sparkathon Retreat and Found in Translation Seed Funding Competition Stimulate Translational Science at MCC! |
On February 7, 2024, the MCC-Office of Translational Science (MCC-OTS) held its inaugural translational science retreat, SPARKATHON, in MCC’s Goldberg Auditorium featuring a Keynote Presentation by Dr. Himisha Beltran (Dana-Farber Cancer Institute) on successes and failures in translational research in the context of her work on mechanisms of resistance in prostate cancer, a fascinating panel discussion highlighting faculty insights and expertise on translational processes, noteworthy rapid-fire talks, impactful networking sessions, an important presentation on COE’s Community-Scientist Program and how our researchers can engage, and a FOUND in TRANSLATION (FiT) Concept Seed Funding Competition, all of which sparked ideas, conversation, collaboration, and networking among researchers, clinicians, and community scientists.
Retreat organizers express their gratitude to everyone who played a part in the success of the retreat – our keynote speaker, panelists, moderators, presenters, judges, and event staff – thank you all!
Congratulations to the Winning Team of the FiT Concept Seed Funding Competition:
Title: Illuminating host-microbiome relationships in triple-negative breast cancer using spatial transcriptomics and long-read metagenomics
Investigators:
Omar Din, PhD (Post-doctoral Scholar)
Kay Yeung, MD (Assistant Clinical Professor)
Rob Knight, PhD (Professor)
And a huge shout-out to all of the teams presenting concepts and the MCC-OTS Liaisons who nominated the compelling translational concepts to be pitched at the retreat – Dr. Sarah Blair (Breast), Dr. Pratibha Binder (Gynecology), Dr. Christina Jamieson (Genitourinary), and Dr. Soo Park (Cutaneous) – we appreciate your engagement and participation!
We are looking forward to another dynamic retreat in 2025!
|
Health Justice, Equity, Diversity, and Inclusion (JEDI) Town Hall |
February 27, 2024 | 12:00 to 1:00 p.m. |
Join us for our first Health Justice, Equity, Diversity, and Inclusion (JEDI) Town Hall on Tuesday, February 27, from Noon to 1 p.m. We will share the department’s journey over the past two years, including our vision, mission, strategic goals, and current key initiatives.
Zoom link: https://uchealth.zoom.us/j/89569847588
Password: healthjedi – all lowercase and no spaces
|
Rare Disease Day is observed every year on 28 February (or 29 in leap years)—the rarest day of the year. Rare Disease Day is the globally-coordinated movement on rare diseases, working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease. Learn how you can help build awareness by sharing your colors.
|
|
|
February 27, 2024 | 4:00 p.m.
Conrad T. Prebys Auditorium
|
February 27, 2024 | 12:00 p.m.
Comer Commons
|
February 28, 2024 | 12:00 p.m.
Comer Commons
|
March 4, 2024 | 12:00 p.m.
Comer Commons
|
March 4, 2024 | 3:00 to 4:00 p.m.
Duane Roth Auditorium
|
Marlaine Figueroa Gray, PhD |
March 6, 2024 | 12:00 p.m.
Zoom
|
March 12, 2024 | 8:30 a.m. to 5:45 p.m.
Goldberg Auditorium
|
March 20, 2024 | 12:00 p.m.
Comer Commons
|
|
|
Surgical Oncologists As Scientists (SOAS) Training Program |
As a member of the next generation of translational surgeon-scientists, you will undergo rigorous training in three disciplines: 1) the tumor microenvironment; 2) techniques of biobanking; and 3) innovation and entrepreneurship. This is a truly unique, one of a kind training program, and is located at an elite institution with a Training Faculty composed of 18 NIH-funded ($28.1 million per year; $18.5 million in direct costs) Faculty Mentors. Applications must be submitted by March 1, 2024.
|
Dr. Maryam Ahmadian Memorial Summer Fellowship Program |
Summer research fellowships are available in Metabolic Disease for deserving and committed UCSD undergraduates focused on obesity, diabetes, and related disorders. Ten week stipends will be available for selected candidates to work in laboratories at UCSD or the Salk Institute led by principal investigators who are members in good standing of the UCSD Diabetes Research Center. Applications are due on March 1, 2024, and should be emailed to saltieladmin@health.ucsd.edu
|
2024 Health Disparities Research Institute Application Period Opens Soon! |
Applications for the 2024 Health Disparities Research Institute (HDRI) will be accepted from February 5 – March 11, 2024. HDRI will take place on August 6 – 9, 2024 and is a unique weeklong program that supports the research career development of promising early-career minority health and health disparities research scientists.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
NIH Resubmission Guideline Changes |
Effective May 25, 2024, for RESUBMISSION APPLICATIONS: The use of markups such as bracketing, indenting, highlighting, bolding, italicizing, underlining, margin lines, change in typography, font, or font color, or any other type of markup should NOT be used to identify changes in Resubmission applications.
Changes made to a Resubmission application should only be outlined in the Introduction attachment. The Introduction must include a summary of substantial additions, deletions, and changes to the application. It must also include a response to weaknesses raised in the Summary Statement. Unless otherwise indicated in the Table of Page Limits, the Introduction may not exceed one page.
NIH Guidance: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-24-061.html
|
The Reach Grant seeks to remove one of these barriers by providing support for important pre-clinical hypothesis-driven research projects that are necessary to move a study from the pre- clinical arena into a clinical trial. The goal of this award is to support translational studies that will result in a phase 1 and/or 2 clinical trial, two to three years from the project end date. The requested budget should be in proportion to the scope of the proposed project and should be for direct costs of $250,000 USD or below over 2 years. A maximum of $125,000 in total direct costs may be requested per year.
Full Proposal Due: March 25, 2024
|
This Notice of Funding Opportunity (NOFO) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic, clinical, or epidemiological cancer research. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Next Deadline: April 1, 2024
|
|
|
| Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab |
Journal of Clinical Oncology
|
Rana McKay, MD (Solid Tumor Therapeutics)
|
|
|
|
|
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial |
Shuvro Nandi, PhD (NPA), Ludmil Alexandrov, PhD (Structural and Functional Genomics), Scott Lippman, MD (Cancer Control Program)
|
|
|
|
| PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway |
Judith Varner, PhD (Solid Tumor Therapeutics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
NIRT 2: Neoadjuvant Immunoradio-therapy in Head Neck Cancer (NIRT 2HNC) |
PI: Joseph Califano, MD
NCT: NCT04938609
|
NIRT ALX+Pembro: A Phase II, Single Arm, Open Label, Multicenter Trial of Neoadjuvant Radiation and Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Previously Untreated Locally Advanced, Resectable, HPV Mediated Oropharynx Cancer |
PI: Joseph Califano, MD
NCT: NCT05787639
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT |
|
|
10th Annual Colorectal Screening Roundtable |
February 27, 2024 | 12:00 to 1:30 p.m. |
Join the Community Outreach & Engagement team and their partners as they commemorate a decade of strides in the fight against colorectal cancer during their 10th Annual Colorectal Cancer Screening Roundtable!
Register Now
|
February 29, 2024 | 4:00 to 6:15 p.m. |
March 1, 2024 | 4:00 to 5:00 p.m. |
Join the Community Outreach & Engagement team and Somali Family services on Friday, March 1st for an in-person (5348 University Ave, Suite 225, San Diego, CA 92105) workshop centered on reproductive health, cervical cancer prevention, and HPV education! Light refreshments will be provided to all attendees.
|
Make SD HPV Cancer Free 2024 Virtual Summit |
March 4, 2024 | 10:00 to 11:30 a.m. |
You are invited to our 4th Annual Make San Diego HPV Cancer Free Summit on Monday, March 4th at 10:00am PST! Help us kick off Pre-Teen Vaccine Week and receive updates on HPV vaccination rates, emerging trends in HPV-related cancers, and a comprehensive exploration of best practices, strategies, and case studies aimed at enhancing HPV cancer prevention within our community. All eligible individuals can earn 1.5hrs of CHES or CEU credit by attending.
Register Now
|
|
|
|
